Jane Royalty
Impact in
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Advanced Breast Cancer Therapies 6
- Oncology 6
- Drug Transport and Resistance Mechanisms 3
- Lung Cancer Research Studies 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Palaniappan Kulanthaivel (5 shared papers)P. Kellie Turner (5 shared papers)Stephen D. Hall (2 shared papers)Alan Y. Chiang (2 shared papers)Joseph V. Bonventre (1 shared paper)Y. Anne Pak (1 shared paper)James A. Bacon (1 shared paper)R Stoltz (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (6 papers)Cancer Research (3 papers)Platelets (2 papers)Molecular Genetics and Metabolism (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesSingaporeUnited Kingdom
In The Last Decade
Jane Royalty
19 papers receiving 343 citations
Peers
Comparison fields: 5 of 77
- Behavioral Neuroscience 17
- Genetics 49
- Biological Psychiatry 10
- Cellular and Molecular Neuroscience 69
- Pharmacology 58
Countries citing papers authored by Jane Royalty
This map shows the geographic impact of Jane Royalty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Royalty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Royalty more than expected).
Fields of papers citing papers by Jane Royalty
This network shows the impact of papers produced by Jane Royalty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Royalty. The network helps show where Jane Royalty may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Royalty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 81 | |
| 2 | 2018 | 74 | |
| 3 | 2008 | 35 | |
| 4 | 2013 | 29 | |
| 5 | 2020 | 17 | |
| 6 | 2016 | 17 | |
| 7 | 2009 | 16 | |
| 8 | 2010 | 14 | |
| 9 | 2006 | 12 | |
| 10 | 2015 | 12 | |
| 11 | 1986 | 10 | |
| 12 | 2015 | 8 | |
| 13 | 2016 | 8 | |
| 14 | 2023 | 5 | |
| 15 | 2016 | 4 | |
| 16 | 2013 | 3 | |
| 17 | 2010 | 2 | |
| 18 | 2016 | 1 | |
| 19 | 2011 | 1 | |
| 20 | 2018 | 1 |
About Jane Royalty
Jane Royalty is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics, having authored 20 papers that have together received 350 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Receptor Mechanisms and Signaling (2 papers), Lung Cancer Research Studies (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Behavioral Neuroscience (17 citations), Genetics (49 citations), Biological Psychiatry (10 citations), Cellular and Molecular Neuroscience (69 citations) and Pharmacology (58 citations). Jane Royalty has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Palaniappan Kulanthaivel, P. Kellie Turner, Stephen D. Hall, Alan Y. Chiang, Joseph V. Bonventre, Y. Anne Pak, James A. Bacon, R Stoltz, John A. Wagner and Jennifer Witcher. Their work appears in journals such as The Journal of Clinical Pharmacology, Cancer Research, Platelets, Molecular Genetics and Metabolism and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.